Discovery Leads to Way to Curb Anthrax Effect

...ng it. “One reason it hadn’t been studied much was because anthrax is rare in humans. It wasn’t until it was realized that it could be used as a bioweapon causing mass infections that interest peaked,” she said. Source-Bio-Bi Technology SRM ...

Tobacco plant based Vaccine against Plague

...acterium have been effectively controlled there as been an increased threat of genetically modified resistant strains of Yersinia pestis produced as a bioweapon to cause bio terrorism. Scientists are not sure whether these antibiotics would work effectively against this mutated bacterium which has led to an in...

bioweapon in Medical Technology

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

...ure to accelerate Phase 1 studies of promising clinical stage drugs or vaccines that address emerging and re-emerging infectious tropical diseases and bioweapon pathogens. The Phase 1B clinical study of SQ109 should be initiated in Q1 2009. SQ-109 is a new diamine antibiotic intended to replace one or mo...

bioweapon in Biological News

The bioweapon is in the post

You might think it would be difficult for a terrorist to obtain genes from the smallpox virus, or a similarly vicious pathogen. Well, it's not. Armed with a fake email address, a would-be bioterrorist could probably order the building blocks of a deadly biological weapon online, and receive them by...

New finding points way to foiling anthrax's tricks

...hogenic forms that produce more than one siderophore base them on the same molecular structure to which siderocalin binds. Anthrax is a potential bioweapon because it is nearly always fatal when inhaled. Its long-lived spores grow rapidly in the lungs, leading to breathing problems and shock within days. ...

Scientists aim to thwart use of flu as bioweapon

...ter, scientists are discussing ways to better understand the flu and also how to prevent the possibility that terrorists could somehow modify flu as a bioweapon to make it even more lethal than it is already. Among the highlights of this week's two-day symposium, hosted by the University of Rochester Center ...